DE:TA50 Stock Latest News
Company AnnouncementsCircio Showcases High-Specificity circVec Advances at ESGCT, Sharpening Gene Therapy Focus5d ago
Company AnnouncementsCircio Aligns Board Compensation with Shareholders Through RSU Issuance1M ago
Company AnnouncementsCircio scraps follow-on share issue after market undercuts placement price1M ago- Company AnnouncementsCircio Holding Registers Share Capital Increase After NOK 200 Million Private Placement1M ago
Company AnnouncementsCircio Raises NOK 200 Million to Accelerate Circular RNA Platform Development1M ago
Company AnnouncementsCircio raises NOK 200m to fast-track in vivo CAR-T ambitions1M agoCompany AnnouncementsCircio boosts circVec gene therapy data and secures funding runway to 20302M ago
Company AnnouncementsCircio and Full Circles join forces on non-viral in vivo cell therapy platform2M ago
Company AnnouncementsCircio bolsters board as it advances circular RNA gene therapy platform2M ago
Company AnnouncementsCircio to Present H1 2026 Results and New circVec Gene Therapy Data2M ago- Company AnnouncementsCircio’s circVec gene therapy platform secures oral slot at top European ESGCT conference2M ago
Company AnnouncementsCircio Strengthens Board With RNA Therapy Veterans Ahead of Clinical Push3M ago
Company AnnouncementsCircio and Tcelltech Join Forces on Next-Generation In Vivo T-Cell Therapies4M ago
- Company AnnouncementsCircio Share Capital Increase Dilutes Major Holder Below 5% Threshold4M ago
- Company AnnouncementsCircio raises NOK 620 million in 2026 to accelerate circular RNA gene therapy platform4M ago
- Company AnnouncementsCircio faces final warrant exercise deadline in key equity financing step4M ago
- Company AnnouncementsCircio insiders boost holdings through warrant exercises during subscription window5M ago
Company AnnouncementsCircio warns investors as warrant trading deadline looms5M ago
Company AnnouncementsCircio Executives Exercise Warrants as Large 2026 Issue Enters Conversion Phase5M ago